# Outlook Therapeutics, Inc.: Form DEF 14A, filed Jan 26, 2026

- Company: [Outlook Therapeutics, Inc.](/companies/otlk.md) (CIK 1649989)
- Form: DEF 14A
- Filed: 2026-01-26
- Accepted by EDGAR: Jan 26, 2026, 22:01 ET
- Period: 2026-03-10
- Accession: 0001140361-26-002406
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm

Filed Jan 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-002406. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.